Diaz P - Search Results

1

Functional characterization and analgesic effects of mixed cannabinoid receptor/T-type channel ligands.

You H, Gadotti VM, Petrov RR, Zamponi GW, Diaz P. You H, et al. Among authors: diaz p. Mol Pain. 2011 Nov 17;7:89. doi: 10.1186/1744-8069-7-89. Mol Pain. 2011. PMID: 22093952 Free PMC article.

2

Analgesic effect of a mixed T-type channel inhibitor/CB2 receptor agonist.

Gadotti VM, You H, Petrov RR, Berger ND, Diaz P, Zamponi GW. Gadotti VM, et al. Among authors: diaz p. Mol Pain. 2013 Jul 1;9:32. doi: 10.1186/1744-8069-9-32. Mol Pain. 2013. PMID: 23815854 Free PMC article.

3

Characterization of novel cannabinoid based T-type calcium channel blockers with analgesic effects.

Bladen C, McDaniel SW, Gadotti VM, Petrov RR, Berger ND, Diaz P, Zamponi GW. Bladen C, et al. Among authors: diaz p. ACS Chem Neurosci. 2015 Feb 18;6(2):277-87. doi: 10.1021/cn500206a. Epub 2014 Nov 5. ACS Chem Neurosci. 2015. PMID: 25314588 Free PMC article.

4

NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors.

Berger ND, Gadotti VM, Petrov RR, Chapman K, Diaz P, Zamponi GW. Berger ND, et al. Among authors: diaz p. Mol Pain. 2014 Dec 6;10:77. doi: 10.1186/1744-8069-10-77. Mol Pain. 2014. PMID: 25481027 Free PMC article.

5

Cav3.2 T-type calcium channels control acute itch in mice.

Gadotti VM, Kreitinger JM, Wageling NB, Budke D, Diaz P, Zamponi GW. Gadotti VM, et al. Among authors: diaz p. Mol Brain. 2020 Sep 1;13(1):119. doi: 10.1186/s13041-020-00663-9. Mol Brain. 2020. PMID: 32873320 Free PMC article.

6

Mastering tricyclic ring systems for desirable functional cannabinoid activity.

Petrov RR, Knight L, Chen SR, Wager-Miller J, McDaniel SW, Diaz F, Barth F, Pan HL, Mackie K, Cavasotto CN, Diaz P. Petrov RR, et al. Among authors: diaz p, diaz f. Eur J Med Chem. 2013 Nov;69:881-907. doi: 10.1016/j.ejmech.2013.09.038. Epub 2013 Sep 29. Eur J Med Chem. 2013. PMID: 24125850 Free PMC article.

7

Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cells.

Petrov RR, Ferrini ME, Jaffar Z, Thompson CM, Roberts K, Diaz P. Petrov RR, et al. Among authors: diaz p. Bioorg Med Chem Lett. 2011 Oct 1;21(19):5859-62. doi: 10.1016/j.bmcl.2011.07.099. Epub 2011 Aug 3. Bioorg Med Chem Lett. 2011. PMID: 21855337 Free PMC article.

8

Modified carbazoles destabilize microtubules and kill glioblastoma multiform cells.

Diaz P, Horne E, Xu C, Hamel E, Wagenbach M, Petrov RR, Uhlenbruck B, Haas B, Hothi P, Wordeman L, Gussio R, Stella N. Diaz P, et al. Eur J Med Chem. 2018 Nov 5;159:74-89. doi: 10.1016/j.ejmech.2018.09.026. Epub 2018 Sep 11. Eur J Med Chem. 2018. PMID: 30268825 Free PMC article.

9

Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain.

Xu JJ, Diaz P, Astruc-Diaz F, Craig S, Munoz E, Naguib M. Xu JJ, et al. Among authors: diaz p. Anesth Analg. 2010 Jul;111(1):99-109. doi: 10.1213/ANE.0b013e3181e0cdaf. Epub 2010 Jun 3. Anesth Analg. 2010. PMID: 20522703 Free PMC article.

10

Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain.

Diaz P, Xu J, Astruc-Diaz F, Pan HM, Brown DL, Naguib M. Diaz P, et al. J Med Chem. 2008 Aug 28;51(16):4932-47. doi: 10.1021/jm8002203. Epub 2008 Jul 31. J Med Chem. 2008. PMID: 18666769

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,092 results

Search Page

Filters